Abstract
The last 20 years of the twentieth century witnessed a dramatic increase in research aimed at determining the mechanisms that regulate feeding behavior. Researchers, prompted by the alarming increase in the prevalence of obesity have identified many brain neuropeptides, especially in the hypothalamus that promote or inhibit food intake. How the complex interactions of these peptides leads to obesity has been clarified somewhat; unfortunately, this has not led to major advances in anti-obesity drug discovery. Continued effort during the first years of the new millennium has led to the discovery of new peptides mainly through inverse pharmacology techniques. In this article, we update information on obestatin, a closely related companion of ghrelin, on neuropeptide S, neuropeptide W, and others. These peptides use both classical and independent regulatory pathways to modulate feeding but often have additional biological activities. Strong arguments support a role in feeding regulation for some peptides. For others, this role remains controversial and further research is needed to clarify their exact effects.
Keywords: G-protein coupled receptor, Rfamide, neuromedins, 26Rfa, VGF, QRFP, hypothalamus, obesity
Central Nervous System Agents in Medicinal Chemistry
Title: Neuropeptides B, S and W, Obestatin/Ghrelin-Associated Peptide, and Others: Really New Feeding Regulatory Peptides?
Volume: 8 Issue: 1
Author(s): Bernard Beck, Carine Pourie and Jean-Louis Gueant
Affiliation:
Keywords: G-protein coupled receptor, Rfamide, neuromedins, 26Rfa, VGF, QRFP, hypothalamus, obesity
Abstract: The last 20 years of the twentieth century witnessed a dramatic increase in research aimed at determining the mechanisms that regulate feeding behavior. Researchers, prompted by the alarming increase in the prevalence of obesity have identified many brain neuropeptides, especially in the hypothalamus that promote or inhibit food intake. How the complex interactions of these peptides leads to obesity has been clarified somewhat; unfortunately, this has not led to major advances in anti-obesity drug discovery. Continued effort during the first years of the new millennium has led to the discovery of new peptides mainly through inverse pharmacology techniques. In this article, we update information on obestatin, a closely related companion of ghrelin, on neuropeptide S, neuropeptide W, and others. These peptides use both classical and independent regulatory pathways to modulate feeding but often have additional biological activities. Strong arguments support a role in feeding regulation for some peptides. For others, this role remains controversial and further research is needed to clarify their exact effects.
Export Options
About this article
Cite this article as:
Beck Bernard, Pourie Carine and Gueant Jean-Louis, Neuropeptides B, S and W, Obestatin/Ghrelin-Associated Peptide, and Others: Really New Feeding Regulatory Peptides?, Central Nervous System Agents in Medicinal Chemistry 2008; 8 (1) . https://dx.doi.org/10.2174/187152408783790640
DOI https://dx.doi.org/10.2174/187152408783790640 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Interconnection of Estrogen/Testosterone Metabolism and Mevalonate Pathway in Breast and Prostate Cancers
Current Molecular Pharmacology Possible Impact of Microglial Cells and the Monocyte-Macrophage System on Suicidal Behavior
CNS & Neurological Disorders - Drug Targets The Anabolic Androgenic Steroid Testosterone Propionate Decreases Recognition Memory in Adult Male Rats
Current Psychopharmacology Sleep Alterations in Non-demented Older Individuals: The Role of Cortisol
Endocrine, Metabolic & Immune Disorders - Drug Targets A synopsis on the linkage between age-related dementias and vascular disorders
CNS & Neurological Disorders - Drug Targets The Role of Complementary and Alternative Medicine in Adolescent Substance Use Disorders
Adolescent Psychiatry Testosterone Action on the Sertoli Cell Membrane: A KIR6.x Channel Related Effect
Current Pharmaceutical Design Promoters and Control Elements: Designing Expression Cassettes for Gene Therapy
Current Gene Therapy Neonatal Environment and Neuroendocrine Programming of the Peripheral Respiratory Control System
Current Pediatric Reviews Sex Differences in Clinical Outcomes of Patients with Stable Coronary Artery Disease after Percutaneous Coronary Intervention
Current Pharmaceutical Design Side Effects of AAS Abuse: An Overview
Mini-Reviews in Medicinal Chemistry New Strategies for Metabolic Support in Cancer
Current Nutrition & Food Science Clinical Utility of Acarbose, an α-Glucosidase Inhibitor in Cardiometabolic Disorders
Current Drug Metabolism Global Life-Long Health Benefits of Repression of Hypothalamic NPY System by Central Leptin Gene Therapy
Current Topics in Medicinal Chemistry The Blood-Brain Barrier as a Cause of Obesity
Current Pharmaceutical Design Follicular Cysts: A Single Sign and Different Diseases. A View from Comparative Medicine
Current Pharmaceutical Design GnRH Agonists and Antagonists in Cancer Therapy
Current Medicinal Chemistry - Anti-Cancer Agents Therapeutic Effects of Renal Denervation on Renal Failure
Current Neurovascular Research Magnetic Field-Assisted Gene Delivery: Achievements and Therapeutic Potential
Current Gene Therapy NPY Receptors as Drug Targets for the Central Regulation of Body Weight
CNS & Neurological Disorders - Drug Targets